Is there a survival benefit from adjuvant chemotherapy for patients with liver oligometastases from colorectal cancer after curative resection?

Zhizhong PanJian-Hong PengJunzhong LinGong ChenXiaojun WuZhenhai LuYuxiang DengYujie ZhaoQiaoqi SuiDesen Wan

Published in: Cancer communications (London, England) (2018)

ACT might offer a prognostic benefit in high-risk patients with CLOs after curative liver resection, but not in low-risk patients. Therefore, patients' risk status should be determined before ACT administration to optimize postoperative therapeutic strategies.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
patient reported outcomes
patient reported